Now that was mean IMO by Brandon Murphy of Simplywallstreet.
About as negative as an assessment of an emerging product company can be given there was no attempt to examine market potential, growth, marketing or any of the factors that will be leading the company forward. In fact, IMO, it was intended as a hit piece and not a fair, unbiased analysis.
Those are my thoughts and welcome differing opinions of substance.
Green Trades
Doesn't change my view of NVTR at all. Just means I get more stock at a cheaper price to sell on the way up. Will do what I always do and that is trade the chart.
NUVECTRA COMPLETES 2,000 U.S. ALGOVITA® SCS SYSTEM IMPLANTATIONS
PLANO, Texas, July 10, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that the Company’s Algovita® Spinal Cord Stimulation (SCS) system has been implanted in over 2,000 patients in the U.S. The Algovita SCS System utilizes one of the most robust internal pulse generators used for spinal cord stimulation and patent-protected stretchable lead technology to deliver four unique stimulation modes to patients seeking non-pharmaceutical relief from chronic pain.
Scott Drees, CEO of Nuvectra, said, “I am excited to recognize Nuvectra’s 2,000th U.S. implant as another significant commercial milestone which further demonstrates our team’s continued success in driving adoption of our Algovita SCS system. This achievement represents a doubling of U.S. implants in just over six months and reflects the world-class professional service provided by our sales force and the clinical efficacy of our system. We continue to receive positive clinical and patient feedback and look forward to accelerating our growth in the expanding SCS market.”
Remember, marketing is cost intensive and front end loaded but necessary for increasing sales growth. All IMO.
Do your own dd. Verify and confirm.
News 
Market Data 
Discover 
